Skip to content
DefDex

Federal award

SRISAI BIOPHARMACEUTICAL SOLUTIONS LLC

W81XWH11C0103

Contract

Obligated and Ceiling

Obligated (net)
$1,669,893.39
Ceiling (potential value, not spending)
$1,670,853.67
Current value
$1,670,853.67
Gross positive obligations
$1,997,014.06

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
SRISAI BIOPHARMACEUTICAL SOLUTIONS LLC · DMAXAMHK9XL3
Awarding agency
Department of War · sub-agency 2100 · office W81XWH
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
R499 · SUPPORT- PROFESSIONAL: OTHER
Industry (NAICS)
541990 · ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES
PIID
W81XWH11C0103
Award type code
D
Actions
39 · Jul 5, 2011 to Jan 7, 2020
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History39

Award actions
DateFYModAction typeObligationCompany in company totals
Jan 7, 2020FY2020P00038B$4,661.63
—
Dec 23, 2019FY2020P00037B−$5,573.41
—
Apr 20, 2018FY2018P00036C−$135,237.27
—
Jan 11, 2018FY2018P00035C−$10,358.02
—
Dec 21, 2017FY2018P00034C$162.24
—
Nov 30, 2017FY2018P00033C−$33,414.62
—
Sep 16, 2017FY2017P00032C$1,067.12
—
Sep 2, 2017FY2017P00031C−$1,827.44
—
Feb 28, 2017FY2017P00030M$897.59
—
Feb 15, 2017FY2017P00029M−$907.15
—
Nov 30, 2016FY2017P00028M−$48.00
—
Jul 21, 2016FY2016P00027B$4,654.91
—
May 31, 2016FY2016P00026B$205,623.74
—
May 10, 2016FY2016P00025B$18,727.74
—
Feb 11, 2016FY2016P00024C$14,148.00
—
Jan 29, 2016FY2016P00023M−$139,754.76
—
Dec 7, 2015FY2016P00022M$0.00
—
Sep 9, 2015FY2015P00021A$25,957.40
—
May 29, 2015FY2015P00020G$368,499.89
—
Apr 16, 2015FY2015P00019M$0.00
—
Mar 19, 2015FY2015P00018M$0.00
—
Nov 5, 2014FY2015P00017M$2,399.76
—
Jul 25, 2014FY2014P00016M$0.00
—
May 30, 2014FY2014P00015G$356,800.24
—
Jun 28, 2013FY2013P00014A$2,595.84
—
May 23, 2013FY2013P00013G$326,205.14
—
May 21, 2013FY2013P00012B$0.00
—
Apr 11, 2013FY2013P00011C$1,442.48
—
Mar 1, 2013FY2013P00010D$2,684.00
—
Dec 31, 2012FY2013P00009D$3,758.10
—
Jul 25, 2012FY2012P00008C$11,679.00
—
Jun 8, 2012FY2012P00007G$320,586.19
—
Apr 19, 2012FY2012P00006M$0.00
—
Feb 8, 2012FY2012P00005D$1,424.96
—
Nov 22, 2011FY2012P00004M$0.00
—
Oct 27, 2011FY2012P00003D$11,419.12
—
Aug 16, 2011FY2011P00002C$17,334.68
—
Jul 25, 2011FY2011P00001C$194,284.29
—
Jul 5, 2011FY20110—$100,000.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.